Literature DB >> 10598840

Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome).

R Barone1, F Nigro, F Triulzi, S Musumeci, A Fiumara, L Pavone.   

Abstract

Mucopolysaccharidosis type III (Sanfilippo syndrome) is an autosomal recessive disorder characterised by progressive nervous system involvement with mental retardation, behavioural problems and seizures. Three patients, of 20 months to 12 years of age, were followed up for 3 years both clinically and by using brain magnetic resonance imaging (MRI). Our results suggest that in MPS III patients MRI findings, including atrophy and abnormal or delayed myelination, may precede the onset of overt neurological symptoms. The increasing neurological morbidity is accompanied by different degrees of progressive atrophic changes, mainly affecting the cerebral cortex and the corpus callosum. However, it appears that, across subjects, the rate of MRI changes is unrelated to the severity of the clinical phenotype. On this basis it could be argued that in MPS III the worsening of the neurological symptoms might not necessarily reflect only the progressive cerebral abnormalities detectable by MRI.

Entities:  

Mesh:

Year:  1999        PMID: 10598840     DOI: 10.1055/s-2007-973503

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  17 in total

1.  A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA.

Authors:  Elsa G Shapiro; Igor Nestrasil; Kathleen A Delaney; Kyle Rudser; Victor Kovac; Nitin Nair; Charles W Richard; Patrick Haslett; Chester B Whitley
Journal:  J Pediatr       Date:  2016-01-16       Impact factor: 4.406

2.  Co-morbidity of Sanfilippo syndrome type C and D-2-hydroxyglutaric aciduria.

Authors:  M Ali Pervaiz; Marc C Patterson; Eduard A Struys; Gajja S Salomons; Cornelis Jakobs; Devin Oglesbee; Salman Kirmani
Journal:  J Neurol       Date:  2011-03-08       Impact factor: 4.849

Review 3.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

Review 4.  Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature.

Authors:  Samuel Groeschel; Wui Khean Chong; Robert Surtees; Folker Hanefeld
Journal:  Neuroradiology       Date:  2006-08-05       Impact factor: 2.804

5.  Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy.

Authors:  Renzo Manara; Elena Priante; Marco Grimaldi; Lucia Santoro; Luca Astarita; Rita Barone; Daniela Concolino; Maja Di Rocco; Maria Alice Donati; Simona Fecarotta; Anna Ficcadenti; Agata Fiumara; Francesca Furlan; Irene Giovannini; Franco Lilliu; Rodica Mardari; Gabriele Polonara; Elena Procopio; Angelica Rampazzo; Andrea Rossi; Graziolina Sanna; Rossella Parini; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2011-04-05       Impact factor: 4.982

Review 6.  Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.

Authors:  Taina Autti; Raimo Joensuu; Laura Aberg
Journal:  Neuroradiology       Date:  2007-03-03       Impact factor: 2.804

Review 7.  Diffusion-weighted MR imaging in leukodystrophies.

Authors:  Zoltan Patay
Journal:  Eur Radiol       Date:  2005-07-15       Impact factor: 5.315

Review 8.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

9.  Blood-brain barrier impairment in an animal model of MPS III B.

Authors:  Svitlana Garbuzova-Davis; Michael K Louis; Edward M Haller; Hiranya M Derasari; Ashley E Rawls; Paul R Sanberg
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

10.  Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B.

Authors:  Coy D Heldermon; Anne K Hennig; Kevin K Ohlemiller; Judith M Ogilvie; Erik D Herzog; Annalisa Breidenbach; Carole Vogler; David F Wozniak; Mark S Sands
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.